Walleye Trading
IMGN

Walleye Trading’s Immunogen Inc IMGN Stock Holding History

Walleye Trading’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-40,200
Closed -$1.19M – 5622
2023
Q4 		$1.19M Buy
40,200
+27,900
+227% +$556K ﹤0.01% 2323
2023
Q3 		$195K Buy
12,300
+6,200
+102% +$103K ﹤0.01% 3620
2023
Q2 		$115K Buy
+6,100
New +$72K ﹤0.01% 3687
2022
Q2 		– Sell
-1,200
Closed -$6K – 5827
2022
Q1 		$6K Sell
1,200
-1,200
-50% -$6.64K ﹤0.01% 5078
2021
Q4 		$18K Buy
+2,400
New +$14.9K ﹤0.01% 4964
2019
Q1 		– Sell
-2,300
Closed -$11K – 4929
2018
Q4 		$11K Buy
2,300
+1,200
+109% +$7.28K ﹤0.01% 4426
2018
Q3 		$10K Buy
+1,100
New +$10.6K ﹤0.01% 4993
2018
Q2 		– Sell
-39,200
Closed -$412K – 5006
2018
Q1 		$412K Buy
+39,200
New +$387K ﹤0.01% 2860

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Trading's IMGN Position: Q1 2024 in Review

Walleye Trading sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 12,812 shares — an estimated $380K sold.

Walleye Trading first reported a position in IMGN in Q2 2015 and held it in 14 quarters. The position peaked at $1.73M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Walleye Trading reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 12,812 Immunogen Inc shares in Q1 2024, an estimated $380K.
  • Walleye Trading first reported a position in Immunogen Inc in Q2 2015 and held it in 14 quarters.
  • Walleye Trading's Immunogen Inc position peaked at $1.73M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.